Impact of BMI on Curative Effect of Neoadjuvant Endocrine Therapy in Elderly Breast Cancer Patients

Rui Ge,Lingjie Zhang,Tianhua Hu,Jiejing Li,Wenhao Tang,Aiqun Cheng

DOI: https://doi.org/10.3969/j.issn.1008-8296.2017.01.010

2017-01-01

Abstract:Objective To explore the association between body mass index (BMI) and the curative effect of neoadjuvant endocrine therapy (NET) in elderly breast cancer patients with hormone receptor positive.Methods A retrospective analysis was made to the clinical data of 107 elderly breast cancer patients with hormone receptor positive at the age of 65 and over,who were hospitalized in Huadong Hospital during the period from Jan.,1995 to Dec.,31,2014 and received NET for more than 3 months;based on BMI,the patients were divided into 2 groups:high BMI group and low/standard BMI group;pathology complete remission (pCR) rate and objective remission (OR) rate of the patients in the 2 groups after treatment were analyzed and compared with x2 test while the difference in relapse free survival (RFS) and breast cancer specific survival (BCSS) after treatment between the 2 groups were analyzed with Kaplan-Meier and log-rank test.Results The median follow-up was 6.8 years (1.7-10.0);the OR rate of the patients in low/standard BMI group after treatment was superior to that of the patients in high BMI group (64.2％ vs 47.5％,P＜0.05);no statistical difference was found between the 2 groups in pCR rate (7.5％ vs7.5％),RFS [48.4％ vs41.1％,HR95％ CI0.93 (0.45-1.96),P=0.86] andBCSS [74.0％ vs59.3％,HR 95 ％ CI 0.74 (0.26-2.07),P=0.56].Conclusions BMI is of certain impact on short-term curative effect of NET of the elderly breast cancer patients with hormone receptor positive and of no obvious impact on long-term survival.